St. Luke's University Health Network


    • Lucente Performs TOPAS Procedure at Allentown Campus

Lucente Performs TOPAS Procedure at Allentown Campus

Urogynecologist Vincent Lucente, MD, First Surgeon to Perform TOPAS Sling Procedure as part of Clinical Study

Vincent Lucente, MD

Allentown, PA (8/29/2010) - Internationally-recognized reconstructive pelvic surgeon Vincent Lucente, MD, is the first physician to perform the innovative TOPAS™ Sling System procedure under a clinical study called TRANSFORM to treat fecal incontinence.

On July 14, 2010, Dr. Lucente completed three patient implants at St. Luke's Hospital - Allentown Campus.

The TRANSFORM (TRreatment of FecAl IncontiNence using the TOPAS Sling System FOR WoMen) study is an Investigational Device Exemption (IDE) clinical trial (Protocol No. WC0807) being conducted at 12 centers throughout the United States. The clinical study is sponsored by American Medical Systems® (AMS), a leading provider of world-class devices and therapies for both male and female pelvic health. TRANSFORM is a prospective, multi-center, single-arm, open-label study which will assess a new surgical procedure for the treatment of fecal incontinence. The objective of the study is to demonstrate that the TOPASTM Sling System effectively treats fecal incontinence (FI) in women over the age of 18.

Fecal incontinence is the inability to control bowel movements, causing stool to leak unexpectedly from the rectum. The condition affects approximately 7% of the female adult population nation wide.

“The problem can range from the occasional leakage of stool while passing gas to a complete loss of bowel control,” says Dr. Lucente. “Fecal incontinence can result from chronic constipation, diarrhea and muscle or nerve damage, which becomes more common as we age. It can also result from injury to the nerves and muscles that control rectal function and that were sustained during child birth many years earlier.”

Changes in diet and drug therapy may be most appropriate to treat relatively mild fecal incontinence, according to Dr. Lucente. However, life can change dramatically for people who have severe fecal incontinence. “A severe condition is considered the accidental loss of solid or liquid stool at least weekly,” he says. “The problem can obviously limit independence and cause horrible embarrassment.”

The innovative TOPAS procedure employs a specially-designed mesh sling to support the posterior pelvic floor at the level of the anorectal junction. The mesh is placed behind the anus through small incisions during a minimally-invasive surgical procedure. The mesh creates a sling to provide extra support to weakened or damaged muscle tissue.

More people should be encouraged to seek treatment for this health condition, said Dr. Lucente. Fecal incontinence is not considered a normal part of aging and, in many cases, it may be treatable.

Dr. Lucente's private practice, The Institute for Female Pelvic Medicine has three office locations. Under the medical direction of Dr. Lucente and the management of Robin Haff, RN, BSN, the St. Luke's Women's Health Research Division at St. Luke's Hospital-Allentown Campus has been first in the United States and the world for many advances in women's health.

For more information about Dr. Lucente, go to

St. Luke’s Again Named One of the Nation's 100 Top Hospitals by Truven Health Analytics
St. Luke's Weight Management Center

Quality Awards